ATE217006T1 - Tetrahydronaphthalin-derivate und ihre therapeutische verwendung - Google Patents
Tetrahydronaphthalin-derivate und ihre therapeutische verwendungInfo
- Publication number
- ATE217006T1 ATE217006T1 AT97939057T AT97939057T ATE217006T1 AT E217006 T1 ATE217006 T1 AT E217006T1 AT 97939057 T AT97939057 T AT 97939057T AT 97939057 T AT97939057 T AT 97939057T AT E217006 T1 ATE217006 T1 AT E217006T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydronaphthaline
- derivatives
- therapeutic use
- selectins
- fucose
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 title 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 abstract 1
- 102000003800 Selectins Human genes 0.000 abstract 1
- 108090000184 Selectins Proteins 0.000 abstract 1
- 230000021164 cell adhesion Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9618520.2A GB9618520D0 (en) | 1996-09-05 | 1996-09-05 | Compounds and their therapeutic use |
| PCT/GB1997/002406 WO1998009977A1 (en) | 1996-09-05 | 1997-09-05 | Tetrahydronapthalene derivatives and their therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE217006T1 true ATE217006T1 (de) | 2002-05-15 |
Family
ID=10799452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97939057T ATE217006T1 (de) | 1996-09-05 | 1997-09-05 | Tetrahydronaphthalin-derivate und ihre therapeutische verwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6133240A (de) |
| EP (1) | EP0931086B1 (de) |
| JP (1) | JP2001500490A (de) |
| AT (1) | ATE217006T1 (de) |
| AU (1) | AU707160B2 (de) |
| CA (1) | CA2264737A1 (de) |
| DE (1) | DE69712351T2 (de) |
| ES (1) | ES2173477T3 (de) |
| GB (1) | GB9618520D0 (de) |
| WO (1) | WO1998009977A1 (de) |
| ZA (1) | ZA978015B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003249641B2 (en) | 2002-05-16 | 2009-08-20 | Glycomimetics, Inc. | Compounds and methods for inhibiting selectin-mediated function |
| JP2006502986A (ja) * | 2002-07-03 | 2006-01-26 | グリコミメティクス， インコーポレイテッド | 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法 |
| US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
| EP1685145A2 (de) * | 2003-11-19 | 2006-08-02 | GlycoMimetics, Inc. | Glycomimetische antagonisten von sowohl e- als auch p-selektinen |
| US7361644B2 (en) * | 2003-11-19 | 2008-04-22 | Glycomimetics, Inc. | Specific antagonist for both E- and P-selectins |
| WO2006127906A1 (en) * | 2005-05-25 | 2006-11-30 | Glycomimetics, Inc. | Heterobifunctional compounds for selectin inhibition |
| JP5175190B2 (ja) * | 2005-08-09 | 2013-04-03 | グリコミメティクス， インコーポレイテッド | シュードモナス由来のｐａ−ｉｌレクチン、ｐａ−ｉｉｌレクチンまたは両方のレクチンのグリコミメティック阻害剤 |
| US7728117B2 (en) | 2005-09-02 | 2010-06-01 | Glycomimetics, Inc. | Heterobifunctional pan-selectin inhibitors |
| US20090176717A1 (en) * | 2006-06-01 | 2009-07-09 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| EP2074132B1 (de) | 2006-10-12 | 2013-05-15 | GlycoMimetics, Inc. | Glycomimetischer ersatz für hexosen und n-acetyl-hexosamine |
| EP2457573A1 (de) * | 2007-02-09 | 2012-05-30 | GlycoMimetics, Inc. | Verfahren zur Verwendung von Glykomimetika für Hexosen und N-Acetyl-Hexosamine |
| US8039442B2 (en) * | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| CA2727788A1 (en) | 2008-06-13 | 2009-12-17 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
| US8410066B2 (en) * | 2009-05-01 | 2013-04-02 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| SI2794626T1 (en) | 2011-12-22 | 2018-02-28 | Glycomimetics, Inc. | E-SELECTINE ANTAGONIST COMPOUNDS |
| LT2928476T (lt) | 2012-12-07 | 2018-05-25 | Glycomimetics, Inc. | Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai |
| HUE045542T2 (hu) | 2014-12-03 | 2019-12-30 | Glycomimetics Inc | E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai |
| WO2017127422A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
| EP3497131B1 (de) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren |
| CA3037850A1 (en) | 2016-10-07 | 2018-04-12 | Glycomimetics, Inc. | Highly potent multimeric e-selectin antagonists |
| CA3054605A1 (en) | 2017-03-15 | 2018-09-20 | Glycomimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
| EP3717013A1 (de) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung |
| EP3732186A1 (de) | 2017-12-29 | 2020-11-04 | GlycoMimetics, Inc. | Heterobifunktionale inhibitoren von e-selektin und galectin-3 |
| US11707474B2 (en) | 2018-03-05 | 2023-07-25 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| USD936390S1 (en) * | 2021-04-23 | 2021-11-23 | Qingdao Jinxiang Tongzhen Textile Co., Ltd. | Wedge pillow set |
| USD936391S1 (en) * | 2021-04-26 | 2021-11-23 | Qingdao Jinxiang Tongzhen Textile Co., Ltd. | Wedge pillow set |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639734A (en) * | 1994-12-20 | 1997-06-17 | Esko; Jeffrey D. | Disaccharide inflammation inhibitors and uses thereof |
-
1996
- 1996-09-05 GB GBGB9618520.2A patent/GB9618520D0/en active Pending
-
1997
- 1997-09-05 DE DE69712351T patent/DE69712351T2/de not_active Expired - Fee Related
- 1997-09-05 JP JP10512372A patent/JP2001500490A/ja active Pending
- 1997-09-05 WO PCT/GB1997/002406 patent/WO1998009977A1/en not_active Ceased
- 1997-09-05 AT AT97939057T patent/ATE217006T1/de not_active IP Right Cessation
- 1997-09-05 ZA ZA978015A patent/ZA978015B/xx unknown
- 1997-09-05 AU AU41282/97A patent/AU707160B2/en not_active Ceased
- 1997-09-05 US US08/924,688 patent/US6133240A/en not_active Expired - Fee Related
- 1997-09-05 EP EP97939057A patent/EP0931086B1/de not_active Expired - Lifetime
- 1997-09-05 CA CA002264737A patent/CA2264737A1/en not_active Abandoned
- 1997-09-05 ES ES97939057T patent/ES2173477T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2173477T3 (es) | 2002-10-16 |
| CA2264737A1 (en) | 1998-03-12 |
| WO1998009977A1 (en) | 1998-03-12 |
| JP2001500490A (ja) | 2001-01-16 |
| AU4128297A (en) | 1998-03-26 |
| US6133240A (en) | 2000-10-17 |
| AU707160B2 (en) | 1999-07-01 |
| DE69712351T2 (de) | 2002-11-07 |
| DE69712351D1 (de) | 2002-06-06 |
| GB9618520D0 (en) | 1996-10-16 |
| EP0931086A1 (de) | 1999-07-28 |
| EP0931086B1 (de) | 2002-05-02 |
| ZA978015B (en) | 1998-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69712351D1 (de) | Tetrahydronaphthalin-derivate und ihre therapeutische verwendung | |
| DE69722656D1 (de) | Bicyclische arylcarboxamide und ihre therapeutische verwendung | |
| GB9514473D0 (en) | Chemical compounds | |
| EP1193270A3 (de) | Pyrrolobenzodiazepine | |
| CY2488B1 (en) | New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for trea. | |
| ATE37375T1 (de) | Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva. | |
| BR9711134A (pt) | Composto e uso de um composto | |
| ATE248175T1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
| ATE210144T1 (de) | Verwendung von steroidderivaten als arzneimittel | |
| ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
| IL112495A0 (en) | Phenylacetic acid derivatives, their preparation and compositions containing them | |
| TR199902357T2 (xx) | Yeni bile�imler. | |
| ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| ES8700666A1 (es) | Procedimiento para la preparacion de derivados de 2-(piridi-lalquilenosulfinil)benzimidazoles n-substituidos como agen- tes antisecretorios gastricos | |
| ATE75743T1 (de) | Hydrazinderivate und ihre verwendung. | |
| DE3689848D1 (de) | Zyklopenta[D]pyrimidinderivate, ihre Herstellung und Verwendung. | |
| CA2269217A1 (en) | New 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives | |
| DE69810960D1 (de) | 2-phenoxyanilin-derivate | |
| ATE250074T1 (de) | 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion- inhibitoren | |
| ATE30429T1 (de) | Acylamino-oxo- oder hydroxy-substituiertealkylamino thiazine und thiazepine. | |
| DE69910568D1 (de) | Furopyridinderivate und ihre therapeutische verwendung | |
| TR200001941T1 (tr) | TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri. | |
| DE19980266D2 (de) | CVD-Reaktor und dessen Verwendung | |
| IL141009A0 (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
| DE60002728D1 (de) | Zytotoxische pyrido[2,3,4-kl]acridinderivate, ihre herstellung und therapeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |